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SUMMARY
Shiga toxin-producing Escherichia coli (STEC), an important foodborne pathogen, can cause
mild to severe bloody diarrhoea (BD), sometimes followed by life-threatening complications such
as haemolytic uraemic syndrome (HUS). A total of 44 O157 strains isolated from different
patients from 2000 through 2009 in Switzerland were further characterized and linked to medical
history data. Non-bloody diarrhoea was experienced by 15.9%, BD by 61.4% of the patients,
and 29.5% developed HUS. All strains belonged to MLST type 11, were positive for stx2
variants (stx2 and/or stx2c), eae and ehxA, and only two strains showed antibiotic resistance. Of
the 44 strains, nine phage types (PTs) were detected the most frequent being PT32 (43.2%) and
PT8 (18.2%). By PFGE, 39 different patterns were found. This high genetic diversity within the
strains leads to the conclusion that STEC O157 infections in Switzerland most often occur as
sporadic cases.
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INTRODUCTION
Escherichia coli, a commensal of the intestinal tract of
humans, as well as many animals, is a Gram-negative,
facultative anaerobic rod. The virulent, disease-
causing E. coli can be divided into two major groups:
gastrointestinal and extragastrointesinal pathogens.
The gastrointestinal category includes enterotoxigenic
E. coli (ETEC), enteropathogenic E. coli (EPEC), en-
teroinvasive E. coli (EIEC), enteroaggregative E. coli
(EAEC) and Shiga toxin-producing E. coli (STEC),
which are significant causes of foodborne diseases.
STEC can lead to severe illness, like haemolytic
uraemic syndrome (HUS), which presents with hae-
molytic anaemia, thrombocytopenia and renal insuf-
ficiency, most often after an onset of diarrhoea (bloody
or non-bloody). In many different O:H serotypes,
there is a group of the so-called top five serogoups
(O26, O103, O111, O145, O157) which are mainly re-
lated to severe illness in humans. Although the im-
portance of non-O157 serovars is being increasingly
recognized, so far O157 has caused most outbreaks
and cases of severe disease throughout the world [1–3].
A stepwise evolutionary model postulates that
the O157 clonal group splits into one lineage, leading
to the common non-sorbitol-fermenting (nSF)
O157:H7 clonal complex, and a second branch of
sorbitol-fermenting (SF) O157:Hx (non-motile)
strains [4]. Recently, SF STEC O157:Hx strains have
been increasingly isolated from clinical cases [5, 6],
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emphasizing the importance of analysing patients’
stool samples for both SF and nSF stx-producing
E. coli O157.
E. coli O157:H7/Hx exist in humans and in the
environment as stx-positive and stx-negative variants
[6, 7]. Friedrich et al. [6] compared the prevalence of
stx-negative strains in SF and nSF E. coli O157 iso-
lated from stools of patients with sporadic cases of
diarrhoea or HUS. They found that the proportion of
stx-negative strains was significantly higher in SF
O157:Hx isolates (12.7%) than in nSF O157:H7/Hx
isolates (0.8%). These authors also identified stx-
negative SF E. coli O157 strains in patients’ stool
samples during three outbreaks of HUS and one
outbreak of diarrhoea and documented loss of stx
genes during outbreaks of human infection [6].
Since few specific data of clinical human O157
STEC strains are available in Switzerland, the aim
of this study was (i) to further characterize all O157
STEC strains sent to the National Centre for
Enteropathogenic Bacteria (NENT) from 2000 to
2009, and (ii) to compare the results with data from
other countries.
METHODS
Strains
A total of 144 STEC strains collected and stored
(x80 xC) by NENT were used for further character-
ization. The strains were isolated between 2000 and
2009 from human faecal samples, collected by hospi-
tals or family doctors. All strains were confirmed to be
STEC by detection of stx genes by polymerase chain
reaction (PCR) with primers VT1 and VT2, based on
sequence targeting of a conserved region between stx1
and stx2 genes and PCR conditions described pre-
viously [8].
Serotyping
O157 strains were distinguished from the collection of
the 144 STEC strains using PCR with primers based
on sequences of the rfbE (per) gene [9]. STEC
O157:H7 strain EDL 933 was included as a control.
The H antigen of the O157 strains was determined by
PCR with primers FLICH7-F and FLICH7-R, and
PCR conditions as described previously [10]. More-
over, all O157 strains were serotyped with an
O157:H7 latex agglutination test (Wellcolex E. coli
O157:H7; Remel, USA).
Further strain characterization
Fermentation of sorbitol was detected on sorbitol
MacConkey agar (SMAC) (Oxoid Ltd, UK). Strains
were further tested by PCR for stx1 and stx2 [11], eae
and eae c1 encoding intimin [12], and ehxA encoding
EHEC haemolysin [13]. Further characterization of
the Shiga toxin type 2 variant B-subunit was done by
PCR–RFLP [14].
Phage-typing
Bacterial phage-typing was performed at the Lab-
oratory of Gastrointestinal Pathogens, GEZI (HPA
Centre for Infections, London, UK) by the methods
described by Khakhria et al. [15].
Multi-locus sequence typing (MLST)
Internal amplicons of seven housekeeping genes (adk,
fumC, gyrB, icdF, mdh, purA, recA) were sequenced
[16] and alleles as well as sequence types (ST) were
assigned in accordance with the E. coliMLST website
(http://mlst.ucc.ie/mlst/dbs/Ecoli).
Genotyping
Pulsed-field gel electrophoresis (PFGE) was per-
formed according to the CDC PulseNet protocol
(http://www.cdc.gov/pulsenet/protocols.htm) with
minor modifications. Briefly, strains were grown on
blood agar at 37 xC overnight. Colonies from blood
agar were resuspended in cell suspension buffer
(OD600=1). The bacterial cell suspension was mixed
with 400 ml of 1.4% Bio-Rad agarose (Bio-Rad,
Germany) and cells were lysed by proteinase K treat-
ment overnight. After lysis the plugs were washed
twice for 15 min in ultrapure water and four times for
an hour in Tris-EDTA (TE) buffer. After washing
with TE buffer, DNA agarose plugs were incubated
overnight in the presence of XbaI (Roche, Germany)
according to the manufacturer’s instructions. Re-
stricted DNA in plug slices was separated in 1%
SeaKem Gold (BioConcept, Switzerland) agarose gel
at 6 V/cm in 0.5r Tris-borate-EDTA buffer cooled to
14 xC in a CHEF-DR III system (Bio-Rad). The pulse
times were ramped from 5 s to 50 s for 20 h at an angle
of 120x. Gels were stained with ethidium bromide and
visualized under UV light transillumination with Gel
Doc (Bio-Rad) and analysed with BioNumerics soft-
ware (Applied Maths, Belgium).
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As a reference Salmonella Braenderup strain H9812
(ATCC BAA 664) was used.
Antimicrobial susceptibility testing
The strains were tested for antimicrobial resistance
by the disk diffusion method according to the pro-
tocols of the Clinical Laboratory Standards
Institute (CLSI, 2008). The panel of antibiotics (disks:
Becton, Dickinson, USA) consisted of ampicillin
(AM), amoxicillin/clavulanic acid (AMC), ceftazi-
dime (CAZ), cefalothine (CF), ciprofloxacin (CIP),
cefpodoxime (CPD), cefotaxime (CTX), cefuroxime
(CXM), cefepime (FEP), cefoxitin (FOX), gentamicin
(GM) and tetracycline (Te). E. coli ATCC 25922
was used as a quality control strain. The strains were
classified as resistant or susceptible to each antibiotic
agent. Strains giving ‘ intermediate’ values were con-
sidered susceptible.
RESULTS
Medical history data
Of the 144 STEC strains collected during 2000–2009,
44 strains from 44 different patients were identified as
O157. Medical history data for these patients are
summarized in Figure 1. Thirteen patients (29.5%)
developed HUS, of which six (46.2%) were male,
and seven (53.8%) female, with an average age of
3.5 years (range 1–15 years). Twenty-seven (61.4%)
patients presented with bloody diarrhoea, seven
(15.9%) with non-bloody diarrhoea, and four (9.1%)
were anaemic. For nine patients no medical history
data was available. Thirty-three (76.7%) patients
were aged f10 years, three (7%) were aged o60
years and seven (16.3%) patients were aged between
10 and 60 years. For one patient (female, presenting
with HUS, diarrhoea and anaemia) no data was
available.
Further strain characterization
Latex agglutination of all 44 strains was positive for
O157, whereas 11 (25%) strains were negative for
H7 agglutination (O157:NM). Results are listed in
Table 1. Nevertheless, these strains were positive for
the fliC gene by PCR.
Four (9.1%) strains fermented sorbitol (SF) on
SMAC, 40 (90.9%) were nSF. All four SF strains
were O157:Hx, 33 (82.5%) of the nSF strains were
O157:H7, and seven (17.5%) strains were O157:Hx.
All 44 E. coli O157 strains tested positive for eae and
ehxA genes. Among the strains, 52.3%, 63.6%,
15.9%, and 20.5% harboured stx1, stx2, stx2c, and
the combination of stx2 and stx2c, respectively
(Table 1).
Phage-typing
Nine different phage types were found (PT2, 4, 8, 14,
23, 32, 49, 50, 71), and six (13.6%) strains could not
be further characterized by phage-typing (RDNC,
Reacts but Does Not Conform to a published typing
pattern). PT2, 4, 14, 50 and 71 appeared only once.
PT8 was found eight times (18.2%), PT23 twice
(4.5%), PT32 nineteen times (43.2%) and PT49 re-
sulted in four (9.1%) of the strains (Table 1).
MLST
All 44 strains belonged to ML ST 11, similar to the
vast majority of eae-positive human STEC O157 iso-
lates.
PFGE typing
PFGE patterns were very heterogeneous except for
eight strains (18.2%). The remaining 36 patterns
showed similarity coefficients between 59% and 94%
(Dice similarity index and UPGMA method). The
dendrogram is displayed in Figure 2.
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Fig. 1.Medical history data of 44 STEC O157 strains isolated from human patients from 2000 to 2009 in Switzerland. HUS,
Haemolytic uraemic syndrome; BD, bloody diarrhoea ; D, non-bloody diarrhoea ; A, anaemia.
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Antimicrobial susceptibility testing
All O157 STEC strains were susceptible to 11 or more
antibiotic agents (AM, AMC, CAZ, CF, CIP, CPD,
CTX, CXM, FEP, FOX, GM). Of the 44 strains, two
(4.5%) were resistant to Te.
DISCUSSION
The 44 strains investigated in this study are highly
representative for Switzerland. This is the total num-
ber of STEC O157 pathogens isolated by NENT from
all human material submitted over the 10-year period
Table 1. Serotypes and virulence factors of STEC O157 strains isolated from human patients from 2000 to 2009 in
Switzerland
Strain no. Serotype Sorbitol stx1 stx2 variants eae c ehxA PT ST Resistance Disease
154-00 O157:H7 x x stx2, stx2c + + 2 11 ND
851-00 O157:H7 x + stx2 + + 14 11 BD
1527-00 O157:H7 x x stx2 + + 4 11 HUS
2965-00 O157:H7 x x stx2, stx2c + + RDNC 11 BD
1688-01 O157:H7 x x stx2, stx2c + + 50 11 BD
2110-01 O157:H7 x x stx2c + + 8 11 BD
1787-02 O157:H7 x + stx2 + + 32 11 HUS
1117-03 O157:H7 x + stx2 + + 32 11 BD, HUS
1357-03 O157:H7 x x stx2, stx2c + + 32 11 HUS
1899-03 O157:H7 x + stx2 + + RDNC 11 Te BD
002-04 O157:[H7] + x stx2 + + 23 11 BD
256-04 O157:H7 x x stx2, stx2c + + 49 11 BD
477-04 O157:H7 x + stx2 + + 32 11 ND
774-04 O157:[H7] + x stx2 + + 23 11 D, HUS
947-04 O157:H7 x x stx2, stx2c + + 49 11 BD
995-04 O157:[H7] x x stx2 + + 8 11 BD
1024-04 O157:[H7] x x stx2 + + 8 11 BD, HUS
1381-04 O157:[H7] x + stx2c + + 8 11 BD
1097-05 O157:H7 x + stx2 + + 32 11 BD
1127-05 O157:H7 x + stx2 + + 32 11 BD
1144-05 O157:H7 x + stx2 + + 32 11 ND
1193-05 O157:H7 x x stx2 + + 32 11 ND
1431-05 O157:H7 x + stx2 + + RDNC 11 ND
1973-05 O157:[H7] + x stx2 + + RDNC 11 BD
2188-05 O157:[H7] x + stx2c + + 8 11 BD
680-06 O157:H7 x x stx2 + + 8 11 A, D, HUS
746-06 O157:[H7] x + stx2c + + 8 11 BD
881-06 O157:H7 x + stx2 + + 32 11 BD, HUS
1206-06 O157:H7 x + stx2 + + 32 11 BD
1346-06 O157:H7 x x stx2, stx2c + + 71 11 Te BD
445-07 O157:H7 x + stx2 + + 32 11 ND
645-07 O157:H7 x + stx2 + + 32 11 BD
1478-07 O157:H7 x x stx2c + + 32 11 BD
1479-07 O157:H7 x + stx2 + + 32 11 A, BD, HUS
1971-07 O157:H7 x x stx2 + + 32 11 A, D, HUS
2298-07 O157:H7 x x stx2, stx2c + + 49 11 BD
787-08 O157:H7 x + stx2 + + RDNC 11 BD, HUS
977-08 O157:[H7] x + stx2c + + 32 11 BD
1620-08 O157:H7 x + stx2 + + 32 11 A, D, HUS
2248-08 O157:[H7] x + stx2c + + 8 11 BD
2437-08 O157:H7 x + stx2 + + 32 11 ND
049-09 O157:H7 x + stx2 + + 32 11 ND
051-09 O157:[H7] + x stx2 + + RDNC 11 ND
1402-09 O157:H7 x x stx2, stx2c + + 49 11 D, HUS
[H7], Negative by latex agglutination serotyping, positive by PCR for fliC ; PT, phage type; RDNC, Reacts but Does Not
Confirm to a published typing pattern; ST, sequence type ; Te, tetracycline ; A, anaemia; BD, bloody diarrhoea ; D, non-
bloody diarrhoea; HUS, haemolytic uraemic syndrome.
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(2000–2009). Switzerland is a small country in the
centre of Europe that is multi-cultural and thus
suffers epidemiological influences from several neigh-
bouring ethnic backgrounds. Moreover, the Swiss are
known to be the most travelled people in the world.
With a population of only 7.1 million, Swiss people
execute about 2.2 million trips abroad per year. These
aspects also warrant international relevance for our
data.
HUS, as a consequence of STEC O157 infection,
was recorded in 13 (29.5%) of the 44 investigated
patients. Of patients with HUS 84.6% were agedf5
years. Of the HUS patients, six (46.2%) were male,
seven (53.8%) were female. A similar age and gender
distribution was reported in a study spanning a 4-year
period in Germany [17].
In contrast, in a study performed over a 7-year
period (2000-2006) involving 3464 STEC O157 iso-
lates in Northern America, the authors observed
fewer HUS cases (6.3%) and fewer HUS patients
aged <5 years (15.3%) [18]. Similar data to these
were obtained in Minnesota, Wales and England [1,
19, 20].
Of the 44 STEC O157 strains, 47.7% harboured
stx2 variants only and 52.3% possessed a combi-
nation of stx1 and stx2 variant genes. No strain was
positive for stx1 only. A similar distribution of stx
genes was found for clinical STEC O157 isolates in
different countries [1, 3, 19–22]. In our study, in all
HUS cases strains harbouring the stx2 gene type were
involved. Nevertheless, there was no evidence that the
stx2 variants or the combination of stx1, stx2 and
K 02-04 stx2 eae PT23
K 774-04 stx2 eae PT23
K 51-09 stx2 eae RDNC
K 1973-05 stx2 eae RDNC
stx2 eae PT32
stx2 eae PT32
K 1193-05 stx2 eae PT32
stx2 eae PT32
stx2 eae PT32
stx2 eae PT14
stx2 eae PT32
stx2 eae PT32
stx2 eae RDNC
stx2 eae PT32
stx2 eae PT32
K 1971-07 stx2 eae PT32
stx2 eae PT32
stx2 eae RDNC
K 1478-07 stx2 eae PT32
stx2 eae PT32
stx2 eae PT32
stx2 eae PT32
stx2 eae PT32
stx2 eae PT32
stx2 eae PT8
K 2965-00 stx2 eae RDNC
K 1527-00 stx2 eae PT4
stx2 eae PT8
stx2 eae RDNC
K 154-00 stx2 eae PT2
K 2298-07 stx2 eae PT49
stx2 eae PT8
K 1346-06 stx2 eae PT71
K 1357-03 stx2 eae PT32
K 680-06 stx2 eae PT8
stx2 eae PT8
K 1688-01 stx2 eae PT50
K 1024-04 stx2 eae PT8
K 995-04 stx2 eae PT8
K 2110-01 stx2 eae PT8
K 645-07      stx1 
K 881-06      stx1 
K 445-07      stx1 
K 1117-03    stx1 
K 851-00      stx1 
K 1206-06    stx1 
K 1787-02    stx1 
K 1899-03    stx1 
K 1620-08    stx1 
K 49-09        stx1 
K 2437-08    stx1 
K 787-08      stx1 
K 1479-07    stx1 
K 1097-05    stx1 
K 1127-05    stx1 
K 1144-05    stx1 
K 477-04      stx1 
K 2188-05    stx1 
K 746-06      stx1 
K 1431-05    stx1 
K 2248-08    stx1 
K 1381-04    stx1 
K 977-08      stx1 stx2 eae PT32
K 1402-09 stx2 eae PT49
K 256-04 stx2 eae PT49
K 947-04 stx2 eae PT49
60 65 70 75 8580 95 10
0
90
Fig. 2. PFGE dendrogram (Dice similarity index and UPGMA method) of 44 STEC O157 strains isolated from human
patients from 2000 to 2009 in Switzerland. PT, Phage type ; RDNC, Reacts but Does Not Confirm to a published typing
pattern ; stx2, stx2 variants (stx2 and/or stx2c).
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stx2c genes are directly associated with the clinical
outcome.
All 44 STEC O157 strains were positive for ehxA
and eae irrespective of the clinical symptoms. Orth &
Wurzner [21] gained comparable results with all iso-
lates investigated in their study being positive for stx2,
eae and ehxA. Similar to other studies [3, 23], intimin
gamma was the eae subtype in our O157:H7 strains.
For years STEC O157 has been classically men-
tioned as being nSF and motile. In 1990 an outbreak
of HUS in Germany, for the first time yielded SF
O157:Hx [24]. This loss of motility in SF STEC O157
is caused by a 12-bp in-frame deletion in fliC that is
required for transcriptional activation of genes in-
volved in flagellum biosynthesis [25]. Although a low
prevalence of SF O157 strains were found in our
strain collection, their occurrence warrants the use of
additional methods other than SMAC.
In Germany SF STEC O157:Hx are the second
most common cause of sporadic HUS [26] and have,
up to 2005, caused two large outbreaks involving 57
HUS cases of which seven children died [26].
Among our isolates four (9.1%) SF strains and
seven (15.9%) nSF strains were non-motile. HUS de-
veloped from 11 classical nSF O157:H7, one atypical
SF O157:Hx and one nSF O157:Hx. Of the other
three patients with SF STEC O157 isolates, two de-
veloped bloody diarrhoea, and from one, no data
was available. Patients with SF STEC O157 were aged
1, 2, 5 and 7 years. In Germany, SF STEC O157 was
present in 13.3–40.5%ofHUS patients, in 7.4–25%of
patients with diarrhoea and only in children aged<3
years [27]. All SF STEC O157:Hx strains harboured
the fliC gene-encoding H7 antigen, as in our study.
To further characterize our strains we performed
phage-typing and PFGE. Among our STEC O157
isolates nine different phage types were found, with
PT8, PT32 and PT49 the most prevalent. In a study
on 415 STEC O157 patients in Wales, the most com-
mon among 19 detected phage types were PT2 and
PT49 showing frequencies of 42.3% and 12.7%, re-
spectively [19]. Similar results were found in an
English study [28], where PT2 (46%) was the most
common phage type, followed by PT49 (17%) and
PT8 (8%). In a recent study from Spain, PT2 was also
the most frequently found phage type in human
STEC O157, followed by PT8 [22]. Therefore, it ap-
pears that Switzerland has a different situation.
PFGE patterns were very heterogeneous except for
eight strains (18.2%). Of these eight strains there were
two sets each consisting of two strains with similar
patterns (set 1: strain K 02-04, male, aged 1 year, and
strain K 774-04, male aged 5 years, both strains iso-
lated in 2004, both stx2, eae positive and PT23; set 2:
strain K 1787-02, male aged 2 years, sample isolated
in 2002, and strain K 1206-06, female aged 45 years,
sample isolated in 2006, both stx1, stx2, eae positive
and PT32) and one set consisting of four equal pat-
terns, all four PT32 and stx1, stx2 and eae positive
(K 447-04, female aged 10 years, sample isolated in
2004 and K 1097-05, male aged 2 years, K 1127-05,
male aged 7 years andK 1144-05, female aged 40 years,
all three samples isolated in 2005). The high genetic
diversity within the strains leads to the conclusion
that STEC O157 infections in Switzerland most often
occur as single cases. Similar to the situation in
Switzerland, only a few STEC O157:H7-associated
outbreaks have been reported in the neighbouring
countries within this time period [29–31].
In our study a very low prevalence of antibiotic
resistance was found for STEC O157 isolates. Only
two strains (4.5%) were resistant to tetracycline. In
England and Wales 20% of human STEC O157
strains collected between 1995 and 1998 were resistant
to one or more antimicrobial agents [20]. Only 1%
of human STEC showed resistance in Germany [32].
Recently, Srinivasan et al. [33] investigated 153 STEC
O157:H7/Hx strains isolated from human faeces,
cows and food in the USA of which >90% showed
resistance to ampicillin and cephalothin. Moreover,
resistance to tetracycline, gentamicin, cefotaxime
and ciprofloxacin was found. High prevalence of re-
sistance was also found in O157:H7 strains from
Spanish people [22], where 38% and 24% of the iso-
lates showed resistance to tetracycline and ampicillin,
respectively.
To summarize, only 30.6% of the STEC strains
isolated from clinical cases from 2000 to 2009 in
Switzerland were STEC O157. SF and nSF strains
were found. All strains were positive for stx2 variants
(stx2 and/or stx2c), eae and ehxA and showed a very
favourable antibiotic resistance situation. The high
genetic diversity within the strains leads to the con-
clusion that STEC O157 infections in Switzerland
most often occur as sporadic cases.
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